Collaboration Agreements And Business Development Activities - Royalty Pharma - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Apr. 03, 2026 |
Apr. 04, 2025 |
|
| Collaborative Arrangements with Glaxo Smith Kline | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Percent of royalty on net sale | 3.00% | |
| Collaborative Arrangements with Royalty Pharma | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Royalty expense | $ 22.9 | $ 20.4 |